Skip to content

Effect of Platelet Rich Plasma (PRP) on the Esthetic Outcome and Scar Formation of Unilateral Cleft Lip Repair

Evaluation of the Effect of Platelet Rich Plasma (PRP) on the Esthetic Outcome and Scar Formation of Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty: A Randomized Clinical Trial

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02958306
Enrollment
24
Registered
2016-11-08
Start date
2016-12-31
Completion date
2018-02-28
Last updated
2019-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral Cleft Lip

Keywords

cleft lip repair, cheiloplasty, PRP, platelet rich plasma

Brief summary

The purpose of this study is to evaluate effect of platelet rich plasma on scar formation of unilateral cleft lip repair.

Detailed description

PRP is a portion of the plasma fraction of autologous blood, having a platelet concentration above baseline values. PRP is made by centrifugation of whole blood (drawn from a peripheral vein and stored in an acid citrate dextrose solution A (ACD-A) anticoagulant), which separates the various components of blood by their specific weight and increases the concentration of platelets. Platelets are a rich source of the complex group of proteins called growth factors (GFs) involved in natural wound healing and in regeneration of injured tissues. GFs are active signals for attracting stem cells into the site of injury and triggering proliferation of these cells. PRP limit inflammation, interacting with macrophages to improve tissue healing and regeneration, promote new capillary growth, and accelerate epithelialization. Platelets in PRP also play a role in host defense mechanism at the wound site by producing signaling proteins that attract macrophages; PRP also may contain a small number of leukocytes that synthesize interleukins as part of a non-specific immune response. Previous studies of PRP have demonstrated antimicrobial activity against Escherichia coli, Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, Candida albicans, and Cryptococcus neoforma. So, PRP is effective in soft tissue healing, having no side effect and showed excellent healing score in skin wound healing.

Interventions

BIOLOGICALplatelet rich plasma

PRP is a portion of the plasma fraction of autologous blood, having a platelet concentration above baseline values

Sponsors

Fayoum University
CollaboratorOTHER
Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Months to 6 Months
Healthy volunteers
No

Inclusion criteria

* Patients with nonsyndromic cleft lip * Primary, unilateral, complete or incomplete cleft lip * Patient's age younger than six months * Lip repair performed by one craniofacial surgeon * Completeness of medical records including preoperative and postoperative photographs at approximately 6 months after surgery

Exclusion criteria

* Patients with syndromic cleft lip * Secondary lip treatment (previous operated cases) * Bilateral cleft lip * Patient older than six months * Associated Cardiac anomalies * Any systemic condition

Design outcomes

Primary

MeasureTime frameDescription
scar width6 monthsscar width through orbicularis oris muscle by ultrasonography

Secondary

MeasureTime frameDescription
vancouver scar scale6 monthsVSS has four parameters, including vascularity, pigmentation, thickness, and pliability giving a range of 0 to 13 in the total score with 0 representing normal skin

Other

MeasureTime frameDescription
Philtral ridge length symmetry index6monthsPhiltral ridge length was measured on the non-cleft side and a correspondent length on the reconstructed cleft side from nasal sill to the peak of Cupid's bow . Philtral ridge symmetry index was calculated as follow:- (Cleft side component value)/(Non clefted side component value)×100

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026